Journal article icon

Journal article

The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.

Abstract:

OBJECTIVES: The aim of this study was to test the effectiveness of Provent, an expiratory nasal resistance valve, to prevent the recurrence of OSA following CPAP withdrawal. DESIGN: Randomised, partially blinded, parallel, placebo-controlled trial. SETTING: Outpatient sleep clinics in the UK (Oxford) and Switzerland (Zurich). PARTICIPANTS: 67 patients with OSA receiving CPAP were randomised to one of three groups for 2 weeks: continuing CPAP, Provent or placebo Provent. MAIN OUTCOME MEASURES...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division,
Expand authors...
Journal:
Thorax
Volume:
68
Issue:
9
Pages:
854-859
Publication date:
2013-09-05
DOI:
EISSN:
1468-3296
ISSN:
0040-6376
URN:
uuid:e16a6946-c1d5-4146-a4e8-becd3ee4f4d8
Source identifiers:
401839
Local pid:
pubs:401839

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP